These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26373433)

  • 1. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.
    Kurabayashi N; Nguyen MD; Sanada K
    EMBO Rep; 2015 Nov; 16(11):1548-62. PubMed ID: 26373433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.
    Kurabayashi N; Sanada K
    Genes Dev; 2013 Dec; 27(24):2708-21. PubMed ID: 24352425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
    García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
    PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.
    Najas S; Arranz J; Lochhead PA; Ashford AL; Oxley D; Delabar JM; Cook SJ; Barallobre MJ; Arbonés ML
    EBioMedicine; 2015; 2(2):120-34. PubMed ID: 26137553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
    Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
    Hämmerle B; Elizalde C; Tejedor FJ
    Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model.
    Hawley LE; Stringer M; Deal AJ; Folz A; Goodlett CR; Roper RJ
    Neurobiol Dis; 2024 Jan; 190():106359. PubMed ID: 37992782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple play of DYRK1A kinase in cortical progenitor cells of Trisomy 21.
    Kurabayashi N; Nguyen MD; Sanada K
    Neurosci Res; 2019 Jan; 138():19-25. PubMed ID: 30227164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
    Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
    J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.
    Lepagnol-Bestel AM; Zvara A; Maussion G; Quignon F; Ngimbous B; Ramoz N; Imbeaud S; Loe-Mie Y; Benihoud K; Agier N; Salin PA; Cardona A; Khung-Savatovsky S; Kallunki P; Delabar JM; Puskas LG; Delacroix H; Aggerbeck L; Delezoide AL; Delattre O; Gorwood P; Moalic JM; Simonneau M
    Hum Mol Genet; 2009 Apr; 18(8):1405-14. PubMed ID: 19218269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
    Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
    J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.
    Canzonetta C; Mulligan C; Deutsch S; Ruf S; O'Doherty A; Lyle R; Borel C; Lin-Marq N; Delom F; Groet J; Schnappauf F; De Vita S; Averill S; Priestley JV; Martin JE; Shipley J; Denyer G; Epstein CJ; Fillat C; Estivill X; Tybulewicz VL; Fisher EM; Antonarakis SE; Nizetic D
    Am J Hum Genet; 2008 Sep; 83(3):388-400. PubMed ID: 18771760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
    Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
    Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model.
    Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH
    Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947
    [No Abstract]   [Full Text] [Related]  

  • 18. DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
    Kariyawasam D; Rachdi L; Carré A; Martin M; Houlier M; Janel N; Delabar JM; Scharfmann R; Polak M
    Endocrinology; 2015 Mar; 156(3):1171-80. PubMed ID: 25490145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome.
    Laguna A; Barallobre MJ; Marchena MÁ; Mateus C; Ramírez E; Martínez-Cue C; Delabar JM; Castelo-Branco M; de la Villa P; Arbonés ML
    Hum Mol Genet; 2013 Jul; 22(14):2775-84. PubMed ID: 23512985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.